Efficient. Ethical. Experienced.

 

Superior central independent review board services that effectively balance the needs of human subjects, sponsors, and sites.

 

Get Started

Follow our easy guide to submit your study to begin the review process.

Follow the step-by-step guide.

Fees

Obtain our Fee Schedule for your next single or multi-site study.

Get a quote.

Versiti Acquires Indianapolis-based

Pearl Pathways and Pearl IRB

Versiti, a national leader in blood health innovation, today announced the acquisition of Pearl Pathways and Pearl IRB, a recognized trusted advisor and preferred partner for enabling innovative and expedited life science product development.

Nimble Independent Review Board

Nimble

Exceptionally quick turnaround times to accelerate your clinical research.

Independent Review Board

Independent

Independently owned and operated means you work directly with us without bureaucratic hoops.

Accredited by AAHRPP

Ethical

AAHRPP accredited. Committed to high quality research and strengthening human subject protection programs.

Pearl IRB is part of Pearl Pathways, a comprehensive life science product development services company. Visit pearlpathways.com for more information about our support services.

Imposter Participants: Fake Participants Causing Real Problems

Fraudulent participation in social and behavioral research is becoming more sophisticated and more common. This blog explores how imposter participants threaten data integrity, the ethical challenges of screening methods, and how IRBs can help researchers strike the right balance between rigor and participant protection.

2025 Holiday Schedule

  Full board meetings occur Monday and Thursday afternoons at 4:30 PM Eastern.  Complete study submissions received by the EOB Monday will be reviewed either the Thursday of the same week or the Monday meeting of the...

OHRP’s Proposed Changes to the Federalwide Assurance Form: An Update

The Office for Human Research Protections (OHRP) has proposed updates to the Federalwide Assurance (FWA) form as part of its ongoing efforts to streamline regulatory processes for institutions conducting human subjects research. These changes aim to simplify the FWA application, reduce administrative burden, and modernize compliance requirements under the Common Rule.